The Tissue Core (the Core) provides both tissue collection and analytic services, and sets the standards for the use of human tissue across all research programs at the UCSF Helen Diller Family Comprehensive Cancer Center (Center), including those that have separately managed tissue-collection efforts. In this latter function. Tissue Core provides oversight and guidance for common issues including tissue consent, standard operating procedures, databases, and quality control (QC). The Core provides tissue-banking services, partially supported by recharge to user programs, including procurement, annotation, processing, storage, tracking, and distribution. Several programs provide direct financial support for Core staff for this purpose. The Core acts as the central hub for the collection of fresh surgical tissue from the hospitals at the Mt. Zion and Moffitt-Long (Parnassus) campuses for those programs without their own tissue- collection efforts. The Core supports the processing, storage, and distribution of blood from patients at UCSF and other sites. In addition, the Core collects, and manages solid tissue from patients at hospitals offsite for several clinical efforts. The Core offers routine histology services, including sectioning, staining, histologic interpretation, and tissue microarray preparation. Distribution of banked material requires approval by the Institutional Review Board (IRB), and by the appropriate programmatic Tissue Utilization Committee.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
5P30CA082103-16
Application #
8693943
Study Section
Subcommittee G - Education (NCI)
Project Start
Project End
Budget Start
2014-06-01
Budget End
2015-05-31
Support Year
16
Fiscal Year
2014
Total Cost
$368,925
Indirect Cost
$135,312
Name
University of California San Francisco
Department
Type
DUNS #
094878337
City
San Francisco
State
CA
Country
United States
Zip Code
94143
Sannino, Sara; Guerriero, Christopher J; Sabnis, Amit J et al. (2018) Compensatory increases of select proteostasis networks after Hsp70 inhibition in cancer cells. J Cell Sci 131:
Lam, Christine; Ferguson, Ian D; Mariano, Margarette C et al. (2018) Repurposing tofacitinib as an anti-myeloma therapeutic to reverse growth-promoting effects of the bone marrow microenvironment. Haematologica 103:1218-1228
Truillet, Charles; Parker, Matthew F L; Huynh, Loc T et al. (2018) Measuring glucocorticoid receptor expression in vivo with PET. Oncotarget 9:20399-20408
Phillips, Kathryn A; Trosman, Julia R; Deverka, Patricia A et al. (2018) Insurance coverage for genomic tests. Science 360:278-279
Phillips, Kathryn A (2018) Evolving Payer Coverage Policies on Genomic Sequencing Tests: Beginning of the End or End of the Beginning? JAMA 319:2379-2380
Puri, Sapna; Roy, Nilotpal; Russ, Holger A et al. (2018) Replication confers ? cell immaturity. Nat Commun 9:485
An, Zhenyi; Aksoy, Ozlem; Zheng, Tina et al. (2018) Epidermal growth factor receptor and EGFRvIII in glioblastoma: signaling pathways and targeted therapies. Oncogene 37:1561-1575
Behr, Spencer C; Villanueva-Meyer, Javier E; Li, Yan et al. (2018) Targeting iron metabolism in high-grade glioma with 68Ga-citrate PET/MR. JCI Insight 3:
Rubenstein, James L; Geng, Huimin; Fraser, Eleanor J et al. (2018) Phase 1 investigation of lenalidomide/rituximab plus outcomes of lenalidomide maintenance in relapsed CNS lymphoma. Blood Adv 2:1595-1607
An, Zhenyi; Knobbe-Thomsen, Christiane B; Wan, Xiaohua et al. (2018) EGFR Cooperates with EGFRvIII to Recruit Macrophages in Glioblastoma. Cancer Res 78:6785-6794

Showing the most recent 10 out of 192 publications